Apr 19 |
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
|
Apr 19 |
Earnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
|
Apr 19 |
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
|
Apr 18 |
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
|
Apr 18 |
AbbVie Q1 Earnings Preview: No Repeat Of Last Year's Q1 Disappointment
|
Apr 18 |
Heard on the Street: AbbVie’s Bet on a Neuroscience Drug Maker Just Got Better
|
Apr 18 |
AbbVie succeeds in late-stage trial for Rinvoq in inflammatory condition
|
Apr 18 |
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
|
Apr 18 |
AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug
|
Apr 18 |
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
|